Here are five things to know.
1. Health Nucleus is the clinical research arm of Human Longevity, a San Diego-based startup that provides commercial gene sequencing services.
2. Human Longevity is collecting tens of millions of genomes, according to geneticist J. Craig Venter, PhD, company co-founder and executive chairman. He added Human Longevity analyzes genomes with machine learning to provide patients with actionable insights into future treatments or lifestyle changes.
3. Patients pay between $4,900 and $25,000 to undergo a day-long assessment that includes cognitive testing, an electrocardiogram and an MRI.
4. About 40 percent of people screened at Health Nucleus have found a serious health problem, Dr. Venter told CNBC.
5. Nearly 2.5 percent “have a major tumor that they don’t know about,” beginning as early as stage zero, Dr. Venter reported to CNBC.
More articles on health IT:
IBM brings ‘new collar’ IT training to US community colleges
House committee hosts hearing on healthcare cybersecurity
Social Security Administration taps IRS exec for CIO
